NLS Pharmaceutics (NLSP) has released an update.
NLS Pharmaceutics Ltd has issued a Common Share Purchase Warrant that allows holders to purchase shares at a set price, exercisable from a future date in 2024 until October 2029. The company has provided an efficient exercise process through electronic delivery and wire transfer payments, with provisions for liquidated damages should there be any delay in share delivery. This financial instrument has not been registered with the SEC and is subject to certain conditions and limitations.
For further insights into NLSP stock, check out TipRanks’ Stock Analysis page.
